课题基金 / 基金详情

HUMAN PROSTATIC 3A HYDROXYSTEROID DEHYDROGENASE

HUMAN PROSTATIC 3A HYDROXYSTEROID DEHYDROGENASE
人前列腺 3A 羟基类固醇脱氢酶
批准号:
6523761
负责人:
HSUEH-KUNG LIN
金额:
$14.55万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-28 至 2005-07-31

项目摘要

项目成果

HSUEH-KUNG LIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): In androgen target tissues 3a-hydroxysteroid dehydrogenases (3a-HSDs) may regulate the occupancy of androgen receptor (AR) by interconverting 5a-dihydrotestosterone (5a-DHT, a potent androgen) with 5a-androstane-3a,17b-diol (3a-diol, a weak androgen). We have obtained type 2 and type 3 3a-HSD cDNAs expressed in human prostate and overexpressed the enzymes in E. coli. Kinetic studies of these recombinant enzymes show that type 3 3a-HSD functions as both a 3a-and 17b-HSD to inactivate active androgens, whereas, type 3 3a-HSD interconverts 5a-DHT with 3a- diol. Levels of 3a-HSD mRNA were higher in primary cultures of prostatic epithelial cells than stromal cells; and elevated levels of 3a-HSD mRNA were observed in primary cultures of epithelial cells derived from benign prostatic hyperplasia and prostatic carcinoma tissues. Expression of steady state levels of 3a-HSD mRNA is up-regulated by epidermal growth (EGF) in human prostatic cell lines, LNCaP (androgen sensitive) and PC3 (androgen insensitive). The focus of this proposal is to examine the physiological functions of type 2 and type 3 3a-HSD in regulating androgen metabolism and their activities in modulating prostatic cell proliferation will be investigated. This will be accomplished by stably transfecting type 2 and type 3 3a-HSD cDNAs into these cells. Second, levels of endogenous type 2 and type 3 3a-HSD transcripts will be examined in RNA extracted from the cell lines and normal prostate using ribonuclease protection assay (RPA). Third, EGF-regulated type 2 and type 3 3a-HSD mRNA levels will be examined using RPA. Changes in 3a-HSD expression mediated by EGF will be examined in cell lysates by immunotitration of the enzyme activity. Fourth, to understand the constitutive and EGF- regulated type 2 and type 3 3a-HSD expression in prostatic cells, the 5'-flanking regions of the 3a-HSD genes will be sequenced and cis-acting elements responsible for transcription regulation of two isoforms will be identified.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
5alpha-Androstane-3alpha,17beta-diol activates pathway that resembles the epidermal growth factor responsive pathways in stimulating human prostate cancer LNCaP cell proliferation.
5alpha-Androstane-3alpha,17beta-diol 激活类似于表皮生长因子响应途径的途径,刺激人前列腺癌 LNCaP 细胞增殖。
DOI: 10.1038/sj.pcan.4500761
发表时间: 2004
期刊: Prostate cancer and prostatic diseases.
影响因子: --
作者: [Zimmerman,RA, Dozmorov,I, Nunlist,EH, Tang,Y, Li,X, Cowan,R, Centola,M, Frank,MB, Culkin,DJ, Lin,H-K]
通讯作者: Lin,H-K
Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival.
雄激素受体信号传导是雄激素敏感的人类前列腺癌细胞增殖和存活所必需的。
DOI: 10.1186/1475-2867-5-8
发表时间: 2005
期刊: Cancer cell international
影响因子: 5.8
作者: [Yang,Qing, Fung,Kar-Ming, Day,WandaV, Kropp,BradleyP, Lin,Hsueh-Kung]
通讯作者: Lin,Hsueh-Kung
HUMAN PROSTATIC 3A HYDROXYSTEROID DEHYDROGENASE
  • 批准号:
    6177945
  • 项目类别:
  • 资助金额:
    $6.6万
  • 财政年份:
    1998
  • 负责人:
    HSUEH-KUNG LIN
  • 依托单位:
HUMAN PROSTATIC 3A HYDROXYSTEROID DEHYDROGENASE
  • 批准号:
    2614194
  • 项目类别:
  • 资助金额:
    $2.24万
  • 财政年份:
    1998
  • 负责人:
    HSUEH-KUNG LIN
  • 依托单位:
HUMAN PROSTATIC 3A HYDROXYSTEROID DEHYDROGENASE
  • 批准号:
    2906335
  • 项目类别:
  • 资助金额:
    $15.6万
  • 财政年份:
    1998
  • 负责人:
    HSUEH-KUNG LIN
  • 依托单位:
HUMAN PROSTATIC 3A HYDROXYSTEROID DEHYDROGENASE
海外基金